RYAMRA Trademark

Trademark Overview


On Wednesday, November 6, 2019, a trademark application was filed for RYAMRA with the United States Patent and Trademark Office. The USPTO has given the RYAMRA trademark a serial number of 79274312. The federal status of this trademark filing is REGISTERED as of Tuesday, November 3, 2020. This trademark is owned by Idorsia Pharmaceuticals Ltd. The RYAMRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

General Information


Serial Number79274312
Word MarkRYAMRA
Filing DateWednesday, November 6, 2019
Status700 - REGISTERED
Status DateTuesday, November 3, 2020
Registration Number6187268
Registration DateTuesday, November 3, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, March 14, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, February 21, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, February 21, 2021FINAL DISPOSITION PROCESSED
Wednesday, February 3, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 11, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 3, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 21, 2020REFUSAL PROCESSED BY IB
Thursday, March 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 5, 2020REFUSAL PROCESSED BY MPU
Thursday, February 13, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 12, 2020NON-FINAL ACTION WRITTEN
Saturday, February 8, 2020ASSIGNED TO EXAMINER
Tuesday, December 24, 2019APPLICATION FILING RECEIPT MAILED
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB